Linagliptin
Also known as Tradjenta (us), Trajenta (india)
Linagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally).
United States
$504
per month
India
$11
per month
You save
−98%save $493/mo · 98% cheaper
1.4M US scripts/yr$713.5M potential annual savings$729.3M US spend/yr
Drag to rotate · 3D structureC25H28N8O2
SMILES: CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C
Compare the price
US price$504per month
India price$11per month
You save$49398% less
Based on 30 EAs per month. US $16.80 vs India $0.36 per EA.
Total over 1 periodSave $493$504 → $11
The bigger picture
Linagliptin is filled about 1.4M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$729.3M
If sourced from India
$15.8M
Potential annual savings
$713.5M
−98%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.